Answers are grounded in this paper and cite their sources.
Case-control study observes unchanged circulating proteinase inhibitor levels in primigravidae with pre-eclampsia, indicating these enzymes may not drive maternal systemic disease manifestations.
The blood levels of alpha 2-macroglobulin, alpha 1-antitrypsin, CT inactivator, antithrombin III and alpha 2-antiplasmin were measured in 18 primigravidae with moderate or severe pre-eclampsia and in 18 gestation-matched primigravidae with uncomplicated pregnancy. The mean levels of the proteinase inhibitors did not differ between the pre-eclampsia and uncomplicated pregnancy groups.
No takes yet. Share an insight, caveat, or question.
Gow et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: